Actively Recruiting
Examining Perivenous Dexamethasone Therapy to Reduce Inflammation and Improve Outcomes After Acute Femoropopliteal Deep Vein Thrombosis
Led by Mercator MedSystems, Inc. · Updated on 2026-09-25
80
Participants Needed
22
Research Sites
109 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the use of a medical procedure involving the Bullfrog Micro-Infusion Device to deliver the anti-inflammatory drug dexamethasone sodium phosphate injection locally around deep veins after deep vein thrombosis DVT recanalization. This study focuses on patients who had DVT symptoms for up to 14 days before the recanalization. The goal is to evaluate whether this local anti-inflammatory treatment helps prevent re-thrombosis and improves symptoms for up to 24 months after the initial procedure. Participants are randomly assigned to receive either the perivascular dexamethasone treatment or a saline sham control delivered around the target vein segment using the catheter device. The study compares these two groups in a quadruple-masked design. Treatments are given following successful recanalization and removal of the acute thrombus from the femoropopliteal veins, which may extend into the iliac veins. During the study, participants will be monitored for the rate of vessel patency, progression to post-thrombotic syndrome, and major adverse events at specified time points up to 6 months and 30 days respectively. They will also follow prescribed anticoagulant and antiplatelet regimens post-procedure. Follow-up includes completion of questionnaires and study visits over up to 24 months to assess outcomes and safety under the lead sponsor Mercator MedSystems, Inc.
CONDITIONS
Brief Title
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
Research Team
K
Kirk Seward, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here